Inspire Medical Systems Future Growth
Future criteria checks 4/6
Inspire Medical Systems is forecast to grow earnings and revenue by 52.2% and 17.5% per annum respectively. EPS is expected to grow by 53.1% per annum. Return on equity is forecast to be 6.3% in 3 years.
Key information
52.2%
Earnings growth rate
53.1%
EPS growth rate
Medical Equipment earnings growth | 18.3% |
Revenue growth rate | 17.5% |
Future return on equity | 6.3% |
Analyst coverage | Good |
Last updated | 02 May 2024 |
Recent future growth updates
Recent updates
Earnings and Revenue Growth Forecasts
Date | Revenue | Earnings | Free Cash Flow | Cash from Op | Avg. No. Analysts |
---|---|---|---|---|---|
12/31/2026 | 1,142 | 67 | 125 | 151 | 11 |
12/31/2025 | 950 | 24 | 91 | 94 | 17 |
12/31/2024 | 782 | -9 | 66 | 65 | 17 |
12/31/2023 | 625 | -21 | 1 | 25 | N/A |
9/30/2023 | 570 | -33 | 8 | 27 | N/A |
6/30/2023 | 526 | -41 | 19 | 34 | N/A |
3/31/2023 | 466 | -44 | 11 | 23 | N/A |
12/31/2022 | 408 | -45 | 2 | 12 | N/A |
9/30/2022 | 348 | -50 | -14 | -7 | N/A |
6/30/2022 | 301 | -44 | -23 | -18 | N/A |
3/31/2022 | 262 | -43 | -27 | -22 | N/A |
12/31/2021 | 233 | -42 | -25 | -20 | N/A |
9/30/2021 | 201 | -47 | -30 | -25 | N/A |
6/30/2021 | 175 | -47 | -38 | -34 | N/A |
3/31/2021 | 134 | -57 | -52 | -49 | N/A |
12/31/2020 | 115 | -57 | -55 | -53 | N/A |
9/30/2020 | 96 | -59 | -57 | -55 | N/A |
6/30/2020 | 81 | -57 | -51 | -49 | N/A |
3/31/2020 | 87 | -41 | -39 | -37 | N/A |
12/31/2019 | 82 | -33 | -36 | -33 | N/A |
9/30/2019 | 72 | -29 | -32 | -29 | N/A |
6/30/2019 | 64 | -25 | -31 | -30 | N/A |
3/31/2019 | 57 | -24 | -24 | -23 | N/A |
12/31/2018 | 51 | -22 | -19 | -19 | N/A |
9/30/2018 | 44 | -21 | -20 | -19 | N/A |
6/30/2018 | 38 | -21 | -19 | -19 | N/A |
3/31/2018 | 33 | -20 | -17 | -17 | N/A |
12/31/2017 | 29 | -18 | -16 | -16 | N/A |
12/31/2016 | 16 | -19 | N/A | -18 | N/A |
12/31/2015 | 8 | -21 | N/A | -22 | N/A |
Analyst Future Growth Forecasts
Earnings vs Savings Rate: 2DR is forecast to become profitable over the next 3 years, which is considered faster growth than the savings rate (0.7%).
Earnings vs Market: 2DR is forecast to become profitable over the next 3 years, which is considered above average market growth.
High Growth Earnings: 2DR is expected to become profitable in the next 3 years.
Revenue vs Market: 2DR's revenue (17.5% per year) is forecast to grow faster than the German market (5.1% per year).
High Growth Revenue: 2DR's revenue (17.5% per year) is forecast to grow slower than 20% per year.
Earnings per Share Growth Forecasts
Future Return on Equity
Future ROE: 2DR's Return on Equity is forecast to be low in 3 years time (6.3%).